Stocks and Investing
Stocks and Investing
Fri, November 19, 2021
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Thu, November 18, 2021
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Roanna Ruiz Downgraded (AVIR) to Hold and Held Target at $11 on, Nov 18th, 2021
Roanna Ruiz of SVB Leerink, Downgraded "Atea Pharmaceuticals, Inc." (AVIR) to Hold and Held Target at $11 on, Nov 18th, 2021.
Roanna has made no other calls on AVIR in the last 4 months.
There are 2 other peers that have a rating on AVIR. Out of the 2 peers that are also analyzing AVIR, all agree with Roanna's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Eric Joseph of "JP Morgan" Downgraded from Buy to Hold and Decreased Target to $16 on, Wednesday, October 20th, 2021
- Matthew Harrison of "Morgan Stanley" Downgraded from Buy to Hold and Held Target at $55 on, Tuesday, October 5th, 2021
Contributing Sources